Skip to content
logo-wfh
logo-gmh
  • Home
  • Guidelines for Hemophilia
    • Principles Of Care
    • Comprehensive Care of Hemophilia
    • Laboratory Diagnosis and Monitoring
    • Genetic Assessment
    • Hemostatic Agents and Prophylaxis
    • Treatment of Specific Hemorrhages
    • Inhibitors to Clotting Factor
    • Specific Management Issues
    • Musculoskeletal Complications
    • Outcome Assessment
    • AAV Gene Therapy
    • Methodology
  • About the WFH Guidelines​
  • Guidelines for VWD
  • Contact Us
  • Home
  • Guidelines for Hemophilia
    • Principles Of Care
    • Comprehensive Care of Hemophilia
    • Laboratory Diagnosis and Monitoring
    • Genetic Assessment
    • Hemostatic Agents and Prophylaxis
    • Treatment of Specific Hemorrhages
    • Inhibitors to Clotting Factor
    • Specific Management Issues
    • Musculoskeletal Complications
    • Outcome Assessment
    • AAV Gene Therapy
    • Methodology
  • About the WFH Guidelines​
  • Guidelines for VWD
  • Contact Us

Author: Hampig Krjalian

WFH

  • WFH
  • WFH USA
  • WFH
  • WFH USA

Events

  • World Congress
  • See all Events
  • World Congress
  • See all Events

Useful Links

  • eLearning
  • Hemophilia World News
  • eLearning
  • Hemophilia World News

For questions, contact [email protected]

© World Federation of Hemophilia 2025

Contact Us